{"id":6965,"date":"1970-01-01T00:00:00","date_gmt":"1970-01-01T00:00:00","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/"},"modified":"1970-01-01T00:00:00","modified_gmt":"1970-01-01T00:00:00","slug":"nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/","title":{"rendered":"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne"},"content":{"rendered":"<p>\n Sophia Antipolis, France.<\/p>\n<p>\n <strong>Nicox S.A. <\/strong>(NYSE Euronext Paris : COX) annonce aujourd\u2019hui la r\u00e9orientation du d\u00e9veloppement du naproxcinod et sa cession, \u00e0 titre exclusif, du droit de proc\u00e9der \u00e0 une \u00e9valuation du d\u00e9veloppement potentiel du naproxcinod et de compos\u00e9s donneurs d\u2019oxyde nitrique (NO) de nouvelle g\u00e9n\u00e9ration \u00e0 un partenaire financier non divulgu\u00e9. L\u2019\u00e9valuation exclura le domaine de l\u2019ophtalmologie, elle sera int\u00e9gralement financ\u00e9e par ce partenaire et ciblera initialement la Dystrophie Musculaire de Duchenne (DMD). Nicox a allou\u00e9 au partenaire non divulgu\u00e9 le droit exclusif, en dehors de l\u2019ophtalmologie, d\u2019investir \u00e0 l\u2019issue de la p\u00e9riode d\u2019\u00e9valuation dans le naproxcinod et les NO-donneurs de nouvelle g\u00e9n\u00e9ration au travers d\u2019une structure ind\u00e9pendante, et ce sous r\u00e9serve que les r\u00e9sultats de l\u2019\u00e9valuation lui soient satisfaisants. Nicox ne poursuivra pas d\u2019activit\u00e9s de d\u00e9veloppement ni d\u2019autres discussions avec des tiers pour le naproxcinod.<\/p>\n<p>\n Le naproxcinod est un m\u00e9dicament en d\u00e9veloppement appartenant \u00e0 la classe des anti-inflammatoires CINODs (Inhibiteurs de Cyclooxyg\u00e9nase Donneurs d\u2019Oxyde Nitrique). En octobre 2013, la Commission Europ\u00e9enne a octroy\u00e9 le statut de m\u00e9dicament orphelin au naproxcinod pour le traitement de la DMD. La DMD est la forme la plus courante et la plus grave des dystrophies musculaires, un groupe de maladies h\u00e9r\u00e9ditaires qui provoquent une faiblesse et une d\u00e9g\u00e9n\u00e9rescence des muscles. Des r\u00e9sultats pr\u00e9cliniques prometteurs obtenus avec le naproxcinod dans des mod\u00e8les de dystrophies musculaires ont \u00e9t\u00e9 pr\u00e9sent\u00e9s lors de la <em>Muscular Dystrophy Association Scientific Conference<\/em> \u00e0 Washington (Columbia, Etats-Unis) en avril 2013 et de l\u2019<em>International Congress of the World Muscle Society<\/em> \u00e0 Asilomar (Californie, Etats-Unis) en octobre 2013 et ont \u00e9t\u00e9 publi\u00e9s dans la revue scientifique <em>Human Molecular Genetics <\/em>d\u00e9but 2014<sup>1<\/sup>.<\/p>\n<p>\n \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.<\/p>\n<p>\n <strong>R\u00e9f\u00e9rence<\/strong><\/p>\n<p>\n 1 Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy, Uaesoontrachoon K, Quinn JL, Tatem KS, Van der Meulen JH, Yu Q, Phadke A, Miller BK, Gordish-Dressman H, Ongini E, Miglietta D, Nagaraju K. <em>Hum Mol Genet.<\/em> 2014, Early online publication Jan 23, 2014.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le naproxcinod est un m\u00e9dicament en d\u00e9veloppement appartenant \u00e0 la classe des anti-inflammatoires CINODs (Inhibiteurs de Cyclooxyg\u00e9nase Donneurs d\u2019Oxyde Nitrique).<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-6965","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne - Nicox\" \/>\n<meta property=\"og:description\" content=\"Le naproxcinod est un m\u00e9dicament en d\u00e9veloppement appartenant \u00e0 la classe des anti-inflammatoires CINODs (Inhibiteurs de Cyclooxyg\u00e9nase Donneurs d\u2019Oxyde Nitrique).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"1970-01-01T00:00:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne\",\"datePublished\":\"1970-01-01T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\\\/\"},\"wordCount\":367,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\\\/\",\"name\":\"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"1970-01-01T00:00:00+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne - Nicox","og_description":"Le naproxcinod est un m\u00e9dicament en d\u00e9veloppement appartenant \u00e0 la classe des anti-inflammatoires CINODs (Inhibiteurs de Cyclooxyg\u00e9nase Donneurs d\u2019Oxyde Nitrique).","og_url":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/","og_site_name":"Nicox","article_published_time":"1970-01-01T00:00:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/"},"author":{"name":"","@id":""},"headline":"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne","datePublished":"1970-01-01T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/"},"wordCount":367,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/","url":"https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/","name":"Nicox recentre le naproxcinod dans la Dystrophie Musculaire de Duchenne - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"1970-01-01T00:00:00+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-recentre-le-naproxcinod-dans-la-dystrophie-musculaire-de-duchenne\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/6965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=6965"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/6965\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=6965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=6965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=6965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}